Arkolith/Insider Trading/PMVP/Form 4

Mack David Henry

President and CEO, DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Jan 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2025Option exercise(M)18K$0.53$9K552K
Dec 3, 2024Option exercise(M)92K$0.53$49K534K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2025Option exercise(M)18K—$00
Dec 3, 2024Option exercise(M)92K—$018K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-001853) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML